Arax Advisory Partners’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8K | Hold |
4,000
| – | – | ﹤0.01% | 1924 |
|
|
2025
Q1 | $9K | Hold |
4,000
| – | – | ﹤0.01% | 1596 |
|
|
2024
Q4 | $14K | Hold |
4,000
| – | – | ﹤0.01% | 1361 |
|
|
2024
Q3 | $16.4K | Hold |
4,000
| – | – | ﹤0.01% | 1164 |
|
|
2024
Q2 | $14.4K | Hold |
4,000
| – | – | ﹤0.01% | 1098 |
|
|
2024
Q1 | $13.2K | Hold |
4,000
| – | – | ﹤0.01% | 735 |
|
|
2023
Q4 | $9.24K | Hold |
4,000
| – | – | ﹤0.01% | 772 |
|
|
2023
Q3 | $5.16K | Hold |
4,000
| – | – | ﹤0.01% | 870 |
|
|
2023
Q2 | $5.28K | Hold |
4,000
| – | – | ﹤0.01% | 855 |
|
|
2023
Q1 | $2.83K | Hold |
4,000
| – | – | ﹤0.01% | 951 |
|
|
2022
Q4 | $3K | Hold |
4,000
| – | – | ﹤0.01% | 899 |
|
|
2022
Q3 | $3K | Hold |
4,000
| – | – | ﹤0.01% | 916 |
|
|
2022
Q2 | $4K | Hold |
4,000
| – | – | ﹤0.01% | 831 |
|
|
2022
Q1 | $4K | Hold |
4,000
| – | – | ﹤0.01% | 835 |
|
|
2021
Q4 | $6K | Hold |
4,000
| – | – | ﹤0.01% | 742 |
|
|
2021
Q3 | $10K | Buy |
+4,000
| New | +$10K | ﹤0.01% | 643 |
|